Specific binding of human chorionic gonadotropin to human corpora lutea in the menstrual cycle
Bolton, R.A.; Coulam, C.B.; Ryan, R.J.
Obstetrics and Gynecology 56(3): 336-338
1980
ISSN/ISBN: 0029-7844 PMID: 6252523 Document Number: 167761
Luteal tissue from 26 premenopausal women undergoing surgery for nonendocrine disease was examined for specific binding to human chorionic gonadotropin. Results showed a nadir in the percentage of binding on day 10, with a gradual increase until maximal binding was obtained on days 22 through 26. Binding then markedly declined to that seen on day 1 of the menses and decreased gradually to its lowest level on day 10.
Document emailed within 1 workday
Related Documents
Capitanio, G.L.; Conte, N.; Ragni, N.; Rossato, P.; Pedretti, E. 1978: Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds Acta Europaea Fertilitatis 9(1): 11-19Mano, H.; Hattori, S.; Furuhashi, Y.; Goto, S.; Tomoda, Y.; Naoi, M. 1984: Specific in vitro effects of methotrexate entrapped into liposomes bearing antibody fragments against human chorionic gonadotropin on cell growth of cultured human choriocarcinoma cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(9): 1775-1780
Presl, J. 1973: Damage in the development of ovarian cycle regulatory mechanisms by human chorionic gonadotropin Ceskoslovenska Gynekologie 38(1): 109-110
Zhang, W.Y. 1989: Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases Zhonghua Yi Xue Za Zhi 69(4): 206-208; 16
Stamenova, M.; Kehayov, I.; Kyurkchiev, S.; Despodova, T. 1990: Production and application of monoclonal antibody specific for human chorionic gonadotropin Folia Biologica 36(2): 81-90
Kosasa, T.S.; Taymor, M.L.; Goldstein, D.P.; Levesque, L.A. 1973: Use of a radioimmunoassay specific for human chorionic gonadotropin in the diagnosis of early ectopic pregnancy Obstetrics and Gynecology 42(6): 868-871
Goldstein, D.P.; Pastorfide, G.B.; Osathanondh, R.; Kosasa, T.S. 1975: A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease Obstetrics and Gynecology 45(5): 527-530
Albrecht, B.A.; MacLeod, J.N.; Daels, P.F. 2000: Differential expression of steroidogenic enzymes by the primary corpora lutea of pregnant mares during equine chorionic gonadotrophin secretion Journal of Reproduction and Fertility. Suppl 56: 627-634
Penny, R.; Olambiwonnu, O.; Frasier, S.D. 1976: Measurement of human chorionic gonadotropin (HCG) concentrations in paired maternal and cord sera using an assay specific for the beta subunit of HCG Pediatrics 58(1): 110-114
Crosignani, P.G.; Brambati, B.; Nencioni, T. 1970: Radioimmunoassay of human chorionic gonadotropin and human placental lactogen in Rh immunized pregnancies Annali di Ostetricia Ginecologia Medicina Perinatale 92(8): 517-521
Garcia, J.; Kholkute, S.D.; Dukelow, W.R. 1993: The efficacy of stored pregnant mares' serum gonadotropin and human chorionic gonadotropin on inducing ovulation in mice Laboratory Animal Science 43(2): 198-199
Wolf, A.S.; Henrichs, I.; Benz, R.; Lauritzen, C. 1985: Influence of human chorionic gonadotropin and prostaglandins on the steroid metabolism of the perfused human placenta Contributions to Gynecology and Obstetrics 13: 162-164
Dericks-Tan, J.S.; Baumann, R. 1976: The maternal and fetal levels of human chorionic gonadotropin, human placental lactogen and prolactin during the perinatal period Geburtshilfe und Frauenheilkunde 36(10): 845-851
Acevedo, H.F.; Hartsock, R.J.; Maroon, J.C. 1997: Detection of membrane-associated human chorionic gonadotropin and its subunits on human cultured cancer cells of the nervous system Cancer Detection and Prevention 21(4): 295-303
Srivastava, P.; Russo, J.; Mgbonyebi, O.P.; Russo, I.H. 1998: Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells Anticancer Research 18(6a): 4003-4010
Dubourdieu, S.; Charbonnel, B.; Massai, M.R.; Marraoui, J.; Spitz, I.; Bouchard, P. 1991: Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration Fertility and Sterility 56(3): 440-445
Tachibana, Y. 1983: Interrelation between serum levels of beta-subunit human chorionic gonadotropin, human placental lactogen and free estriol during the third trimester of pregnancy Nihon Sanka Fujinka Gakkai Zasshi 35(10): 1727-1731
Nachman, S.A.; Chasalow, F.I.; Navaie-Waliser, M.; Blethen, S.L.; Tropper, P. 1996: Testing cord blood human chorionic gonadotropin as a surrogate marker for early identification of human immunodeficiency virus-1 infection in children Journal of Perinatology: Official Journal of the California Perinatal Association 16(6): 449-454
Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Tulchinsky, D.; Hobel, C.J. 1973: Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17 alpha-hydroxyprogesterone in human pregnancy. 3. Early normal pregnancy American Journal of Obstetrics and Gynecology 117(7): 884-893